EU MEDICINES BODY MIGHT EASE MILK OF MAGNESIA RESTRICTIONS
July 1st, 2013
EUROPEAN institution at the heart of the current controversy over Milk of Magnesia (magnesium hydroxide) sales in the UK has told Industrial Minerals it is considering raising the maximum level of sulfate within these medicines to 1%, up from 0.5% at present.A spokeswoman for the European Pharmacopoeia Commission in Strasbourg, France, said the body had “received a request for revision of the respective monograph [manufacturing rules] to widen the limit for sulfates to 1.0% and at the same time to change the analytical method [for measuring such content] to ion ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.